Growth Engineer, Flow Neuroscience
Share options offered
1 day a week in office
Medically certified depression treatment at home
Job no longer available
Medically certified depression treatment at home
21-100 employees
Job no longer available
Share options offered
1 day a week in office
21-100 employees
Company mission
To revolutionise the treatment of mental illness, to enable everyone to live their best life.
Role
Who you are
- 3+ years experience as a software engineer
- As motivated by the business impact as by the engineering. It's part of the developer’s role to challenge when they feel like the work won’t impact the user experience and continually improve the data and testing setup
- Great product sense - an ability to have strong opinions on what the team should do to move the conversion goal
- Experience of building and shipping software, probably in a small team in a startup environment - change is exciting and not daunting to you
- Growth mindset - you’re resilient, transparent when you make mistakes and eager to learn and grow. No one has all the answers and we’ll work together to figure it out
- Extensive frontend JavaScript experience
- HTML, JavaScript, Python
- Experience analysing data to spot user behaviour trends
- Performance marketing data experience
Desirable
- Django
- Wagtail
- TailwindCSS
- Experience with DevOps
What the job involves
- We are looking for a data-driven developer to join the growth team at Flow
- This position will be the founding developer on this new team, working alongside the Head of D2C to drive growth across the consumer business
- This work will go where it makes the most business sense - it will start with optimisation journeys through the website and building acquisition tools, but could stretch to building predictive models for marketing acquisition or creating the foundations for strong SEO
- The first goal of the team is to drive significant improvements in conversion rate. Every improvement we make translates to thousands of new people getting access to a life-changing depression treatment
- Work in the growth team to improve conversion and value of users we acquire
- Base everything you do on the latest evidence, learning fast and often
- Work with a continuous discovery mindset
- Rigorously test every idea, testing assumptions through data, jumping on a user testing call with the product lead if it’s helpful
- Additional info about the stack:
- Amplitude for FE product analytics
- VWO for AB testing
- Google analytics 4 for marketing channel tracking
- A key part of the role will be to add to this and improve it
Application process
- Intro call with Laura (Head of D2C, non technical) - 30 mins
- Interview with Conor (Product) - 1 hour
- Technical task with our CTO and co-founder Erik - Complete at home, 1 hour call to share
- Final interview with Sam, Chief Growth Officer - 30 mins
Salary benchmarks
Our take
Despite the prevalence of mental health conditions such as anxiety and depression, medicine has been relatively slow to respond with new treatment options. Particularly, at-home treatment has been limited to medication, or more recently virtual talk therapy. Flow Neuroscience has developed a wearable tDCS (transcranial Direct Current Stimulation) device for patients to use at home, with a complementary app to help manage the symptoms of major depressive disorder.
Flow's device delivers a gentle electrical current to the part of the brain that regulates mood, offering a non-drug alternative that patients can use outside of a clinical setting under remote supervision. The treatment has already been used by more than 55,000 people across Hong Kong, the UK, Switzerland and other parts of Europe. Clinical research has produced promising results, including studies showing that a significant proportion of patients experience symptom improvement within weeks of starting treatment.
In a major milestone for the company, the US Food and Drug Administration approved Flow's FL-100 headset to treat moderate to severe major depressive disorder in adults. This approval makes it the first at-home brain stimulation device cleared for depression treatment in the US. With this, the company plans to launch the device in the US later in 2026 as a prescription treatment, expanding its reach and bringing its technology to a much larger patient population.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 3 rounds)
Aug 2021
$9.9m
SERIES A
Jul 2019
$1.6m
EARLY VC
Total funding: $12.5m
Company HQ
Gamla staden, Malmö, Skåne County
Leadership
Daniel Månsson
(Co-Founder & Chief Science Officer)After co-founding Flow Neuroscience in 2015, Daniel served as the CEO until 2022. Previously, he was a Clinical Psychology at Sykehuset Østfold.
Erik M. Rehn
(Co-Founder & CTO)Erik is also the co-founder of Skry, where he currently serves as a Board Member. Previously, he co-founded Stockholm.AI where he served a the VP.
Erin Sivyer Lee
(CEO)Prior to joining Flow Neuroscience in 2022, Erin was the VP of Global Operations & USA Managing Director at Babylon and the Director of Community Operations Northern Europe and Middle East & Head of EMEA Innovation at Uber. She also spent 8 years at Google as an Analyst/Program Lead and in New Product Strategy & Operations.
Share this job
View 1 more job at Flow Neuroscience